Trial Profile
Prospective study investigating effect of delay in ranibizumab injections on prognosis in age-related macular degeneration patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Feb 2016
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Age-related macular degeneration
- Focus Therapeutic Use
- 05 Feb 2016 New trial record